TY  - GEN
AU  - Khan,O A
AU  - Gore,M
AU  - Lorigan,P
AU  - Stone,J
AU  - Greystoke,A
AU  - Burke,W
AU  - Carmichael,J
AU  - Watson,A J
AU  - McGown,G
AU  - Thorncroft,M
AU  - Margison,G P
AU  - Califano,R
AU  - Larkin,J
AU  - Wellman,S
AU  - Middleton,M R
TI  - A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
SN  - 1532-1827
PY  - 2011///0419
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Dacarbazine
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasms
KW  - Neutropenia
KW  - chemically induced
KW  - Phthalazines
KW  - Piperazines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Thrombocytopenia
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2011.8
ER  -